Researchers reveal new therapeutic way to block oncogenic RA

As a 10-year journey comes to fruition, MUSC Hollings Cancer Center researcher John O'Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers.

Related Keywords

United States , American , Shohei Koide , John Obryan , Emily Henderson , Hollings Cancer Center , University Of South Carolina , Perlmutter Cancer Center At New York University , American Cancer Society , Department Of Cell , Cancer Center , Johno Bryan , Molecular Pharmacology , Experimental Therapeutics , Medical University , Perlmutter Cancer Center , New York University , Cancer , Iochemistry , Fell , Cell Proliferation , Drugs , Education , Lung Cancer , Medicine , Ucleotide , Nucleotides , Mh , Harmacology , Proliferation , Protein , As Proteins , Research , Herapeutics ,